Purchase Order 75N93020P01411

Award Date 9/25/20
Potential Completion Date 9/27/21
Potential Value $318K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77021, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $44,250 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for microarray testing services to support NIAID's infectious disease research, which aligns with the NIH's mission of advancing medical research to improve public health. This contract is not associated with a larger...
This federal contract award, valued at $6,361,900.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for whole genome sequencing services, including the sequencing of 1,400 whole genomes with delivery of raw data, and 250 whole genomes with delivery of data, interpretation, and reports. The contract was awarded as a firm-fixed-price purchase order with no set-aside...
Baylor Genetics will provide custom microarray sample testing services to the National Institute of Allergy and Infectious Diseases (NIAID) under a $32,550 firm fixed-price purchase order. As the prime contractor, Baylor Genetics will perform the work at its facilities in Houston, Texas to support NIAID's research efforts. No subcontractors or set-aside designations were identified. NIAID is a part of the National Institutes of Health within the Department of Health and Human Services, which...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health, to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The $68,900.00 contract is for chromosomal microarray analysis services, with a period of performance through April 17, 2023. Baylor Genetics is a for-profit limited liability company that specializes in...
This is a $730,306.58 firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine. The contract provides genetic testing services, including whole exome sequencing, comparative genomic hybridization, and whole genome sequencing coupled with RNA sequencing, in support of NIAID's Centralized Sequencing Initiative to obtain genetic testing...
Baylor Genetics was awarded a $59,000 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide clinical single nucleotide polymorphism and comparative genomic hybridization microarray testing services. The firm fixed price contract runs from July 14, 2023 through September 30, 2023 and will be performed in Houston, Texas. No subcontractors or set aside designations were identified. The testing services align with NIH's mission to...
This is a $235,200 firm fixed-price purchase order awarded by the National Human Genome Research Institute, part of the National Institutes of Health within the Department of Health and Human Services, to Baylor Miraca Genetics Laboratories LLC (dba Baylor Genetics) for whole genome sequencing and clinical testing services in support of the Undiagnosed Disease Program (UDP). The contract has an ultimate completion date of August 22, 2025 and was awarded on August 23, 2024. No set-aside...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine a one-year, firm fixed-price purchase order valued at $1,035,907.10 to provide genomics services for the agency's Centralized Sequencing Initiative in response to the COVID-19 pandemic. As part of this initiative, Baylor College of Medicine will sequence SARS-CoV-2 virus samples to support NIAID's research efforts. No subcontractors or set-aside designations were identified....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $232,285.00 firm fixed price purchase order to Baylor College of Medicine, a private university and non-profit educational institution, for whole genome sequencing services. The order includes 200 standard and 5 rapid samples, with a completion date of October 31, 2022. This purchase order is not associated with a larger contract vehicle, and does not have a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Baylor College of Medicine, a private, non-profit university, for whole genome sequencing of 200 samples. The $240,621 contract has a completion date of August 15, 2021 and was awarded without a set-aside on July 20, 2021. The contract originated from a request for quotes solicitation for clinical whole genome sequencing...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $317,775.00 firm fixed-price purchase order to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, for the provision of genomics services to support the NIAID Centralized Sequencing Initiative related to the COVID-19 response. Baylor Genetics, a for-profit genetics testing laboratory, has previously provided various genetic testing services to NIAID through other prime contract awards. This contract does not have a set-aside designation. The services delivered under this award support NIAID's infectious disease research and the NIH's broader mission to advance medical research and improve public health.

Generated 3/21/24, 9:17 PM